In this small cohort of selected CH cases, targeted genetic analysis revealed potential pathogenic variants in TPO, DUOX2, PAX8, TSHR, and TG. Seven variants either truncated the protein, affecting key functional domains, or had previously been demonstrated to result in loss of function in vitro. The gene discussed is PAX8; the disease is cyclic hematopoiesis.